How do you decide on adjuvant therapy in a patient with a Stage IA uterine carcinosarcoma without any myometrial invasion?
2
1 Answers
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network
There is no good prospective study. Our approach, based on outcome and retrospective data (including NCDB), is brachy plus chemo.
https://www.ncbi.nlm.nih.gov/pubmed/30170976
This is paper I was referring to. With all the caveats of NCDB studies, it givess some objective information where prospective...